Cargando…

HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later

AIMS/HYPOTHESIS: HLA genes, islet autoantibodies and residual C-peptide were studied to determine the independent association of each exposure with diabetic retinopathy (DR), 15 years after the clinical onset of type 1 diabetes in 15–34 year old individuals. METHODS: The cohort was identified in 199...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Richard A., Agardh, Elisabet, Lernmark, Åke, Gudbjörnsdottir, Soffia, Smith, Nicholas L., Siscovick, David S., Törn, Carina
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055880/ https://www.ncbi.nlm.nih.gov/pubmed/21412422 http://dx.doi.org/10.1371/journal.pone.0017569

Ejemplares similares

Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2022)

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies
por: Maziarz, M, et al.
Publicado: (2015)

Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2020)

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022)

Etiology of Autoimmune Islet Disease: Timing Is Everything
por: Lernmark, Åke
Publicado: (2021)

Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
por: Andersson Svärd, Agnes, et al.
Publicado: (2020)

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
por: Kwon, Bum Chul, et al.
Publicado: (2022)

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes
por: Zhao, Lue Ping, et al.
Publicado: (2016)

Complete blood counts with red blood cell determinants associate with reduced beta‐cell function in seroconverted Swedish TEDDY children
por: Salami, Falastin, et al.
Publicado: (2021)

Association of HLA-DQ Heterodimer Residues −18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial–Type 1
por: Zhao, Lue Ping, et al.
Publicado: (2022)

Comparison of Measurements of Autoantibodies to Glutamic Acid Decarboxylase and Islet Antigen-2 in Whole Blood Eluates from Dried Blood Spots Using the RSR-Enzyme Linked Immunosorbent Assay Kits and In-House Radioimmunoassays
por: Persson, Anders, et al.
Publicado: (2010)

Islet Cell Antibodies Represent Autoimmune Response Against Several Antigens
por: Månsson, Lisa, et al.
Publicado: (2001)

Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes
por: Eising, Stefanie, et al.
Publicado: (2011)

Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study
por: Li, Qian, et al.
Publicado: (2020)

Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies
por: Koskinen, Maarit K, et al.
Publicado: (2017)

Extended family history of type 1 diabetes in HLA‐predisposed children with and without islet autoantibodies
por: Kuusela, Salla, et al.
Publicado: (2020)

Development of Type 1 Diabetes in Wild Bank Voles Associated With Islet Autoantibodies and the Novel Ljungan Virus
por: Niklasson, Bo, et al.
Publicado: (2003)

Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2015)

Electrochemiluminescence Assays for Human Islet Autoantibodies
por: Gu, Yong, et al.
Publicado: (2018)

Birth and coming of age of islet autoantibodies
por: Bonifacio, E., et al.
Publicado: (2019)

Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2016)

Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years
por: Pöllänen, Petra M, et al.
Publicado: (2020)

Human Leukocyte Antigen (HLA) and Islet Autoantibodies Are Tools to Characterize Type 1 Diabetes in Arab Countries: Emphasis on Kuwait
por: Jahromi, Mohamed, et al.
Publicado: (2019)

Treatment of diabetic rats with encapsulated islets
por: Sweet, Ian R, et al.
Publicado: (2008)

Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy
por: Agardh, Elisabet, et al.
Publicado: (2011)

Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children
por: Bonifacio, Ezio, et al.
Publicado: (2018)

Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection
por: Lin, Jake, et al.
Publicado: (2023)

Islet Autoantibody Testing: An End to the Trials and Tribulations?
por: Bingley, Polly J., et al.
Publicado: (2013)

Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
por: Gu, Yong, et al.
Publicado: (2017)

Prevalence of Islet Autoantibodies in Type 1 Diabetes
por: Dayal, Devi, et al.
Publicado: (2017)

Anti-Islet Autoantibodies in Type 1 Diabetes
por: Kawasaki, Eiji
Publicado: (2023)

Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome
por: Gu Urban, Gucci Jijuan, et al.
Publicado: (2015)

HLA, infections and inflammation in early stages of atherosclerosis in children with type 1 diabetes
por: Odermarsky, Michal, et al.
Publicado: (2017)

Excess Body Weight and Cancer Risk in Patients with Type 2 Diabetes Who Were Registered in Swedish National Diabetes Register – Register-Based Cohort Study in Sweden
por: Miao Jonasson, Junmei, et al.
Publicado: (2014)

Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study
por: Törn, Carina, et al.
Publicado: (2022)

Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden
por: Zhao, Lue Ping, et al.
Publicado: (2021)

High Plasma Levels of Islet Amyloid Polypeptide in Young with New-Onset of Type 1 Diabetes Mellitus
por: Paulsson, Johan F., et al.
Publicado: (2014)

Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study
por: Carlsson, Annelie, et al.
Publicado: (2020)

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
por: Burbelo, Peter D., et al.
Publicado: (2010)

Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors
por: Diamantopoulos, Stavros, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_00anlf4640voonkm5ds2a3dnra